BIM
JAZZ icon

BRC Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

BRC Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,893
Closed -$2.67M – 194
2016
Q2 		$2.67M Buy
+18,893
New +$2.79M 0.46% 57
2014
Q1 		– Sell
-4,265
Closed -$540K – 161
2013
Q4 		$540K Sell
4,265
-803
-16% -$83.1K 0.09% 75
2013
Q3 		$466K Sell
5,068
-1,128
-18% -$91K 0.07% 98
2013
Q2 		$426K Buy
+6,196
New +$379K 0.08% 105

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BRC Investment Management's JAZZ Position: Q3 2016 in Review

BRC Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 18,893 shares — an estimated $2.67M sold.

BRC Investment Management first reported a position in JAZZ in Q2 2013 and held it in 4 quarters. The position peaked at $2.67M in Q2 2016. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • BRC Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • BRC Investment Management sold 18,893 Jazz Pharmaceuticals shares in Q3 2016, an estimated $2.67M.
  • BRC Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • BRC Investment Management's Jazz Pharmaceuticals position peaked at $2.67M in Q2 2016.
  • 326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.